ReviewJournal of hematology & oncology2022

Targeting regulated cell death (RCD) with small-molecule compounds in triple-negative breast cancer: a revisited perspective from molecular mechanisms to targeted therapies.

Minru Liao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.